Detection and differentiation of inflammatory versus fibromatous Crohn's disease strictures: Prospective comparison of 18F-FDG-PET/CT, MR-enteroclysis, and transabdominal ultrasound versus endoscopic/histologic evaluation

Inflammatory Bowel Diseases

Volumn 18, Issue 12, 2012, Pages 2252-2260

  Lenze, Frank ^a   Wessling, Johannes ^a   Bremer, Janbernd ^a   Ullerich, Hansjoerg ^a   Spieker, Tillmann ^a   Weckesser, Matthias ^a   Gonschorrek, Sarid ^a   Kannengieber, Klaus ^b   Rijcken, Emile ^a   Heidemann, Jan ^a   Luegering, Andreas ^a   Schober, Otmar ^a   Domschke, Wolfram ^a   Kucharzik, Torsten ^b   Maaser, Christian ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Klinikum Lueneburg   (Germany)

Author keywords

computed tomography; Crohn's disease; magnetic resonance imaging; positron emission tomography; stricture; ultrasonography

Indexed keywords

ENEMA; FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FIBROMATOUS CROHN DISEASE STRICTURE; GASTROINTESTINAL ENDOSCOPY; HISTOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY CROHN DISEASE STRICTURE; INTESTINE PREPARATION; INTESTINE STENOSIS; INVASIVE PROCEDURE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCORING SYSTEM;

ADULT; COLON; COLONOSCOPY; CROHN DISEASE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84869206610     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.22930     Document Type: Article

References (25)

1. Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis. 2002; 8: 244-250.
2. Sorrentino D,. Role of biologics and other therapies in stricturing Crohn's disease: what have we learnt so far? Digestion. 2008; 77: 38-47.
3. Bernell O, Lapidus A, Hellers G,. Risk factors for surgery and postoperative recurrence in Crohn's disease. Ann Surg. 2000; 231: 38-45.
4. Heimann TM, Greenstein AJ, Lewis B, et al. Comparison of primary and reoperative surgery in patients with Crohns disease. Ann Surg. 1998; 227: 492-495.
5. Wettergren A, Christiansen J,. Risk of recurrence and reoperation after resection for ileocolic Crohn's disease. Scand J Gastroenterol. 1991; 26: 1319-1322.
6. Toruner M, Loftus EV Jr, Harmsen WS, et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology. 2008; 134: 929-936.
7. Torigian DA, Huang SS, Houseni M, et al. Functional imaging of cancer with emphasis on molecular techniques. CA Cancer J Clin. 2007; 57: 206-224.
8. Schick V, Franzius C, Beyna T, et al. Diagnostic impact of 18F-FDG PET-CT evaluating solid pancreatic lesions versus endosonography, endoscopic retrograde cholangio-pancreatography with intraductal ultrasonography and abdominal ultrasound. Eur J Nucl Med Mol Imaging. 2008; 35: 1775-1785.
9. Cronin CG, Swords R, Truong MT, et al. Clinical utility of PET/CT in lymphoma. AJR Am J Roentgenol. 2010; 194: W91-W103.
10. Lebiedz P, Maaser C, Franzius C, et al. Pet-Ct - a new diagnostic tool for differentiation between inflammatory and fibromatous stenosis in Crohn's disease. Gastroenterology. 2005; 128: A-310.
11. Das CJ, Makharia G, Kumar R, et al. PET-CT enteroclysis: a new technique for evaluation of inflammatory diseases of the intestine. Eur J Nucl Med Mol Imaging. 2007; 34: 2106-2114.
12. Meisner RS, Spier BJ, Einarsson S, et al. Pilot study using PET/CT as a novel, noninvasive assessment of disease activity in inflammatory bowel disease. Inflamm Bowel Dis. 2007; 13: 993-1000.
13. Louis E, Ancion G, Colard A, et al. Noninvasive assessment of Crohn's disease intestinal lesions with (18)F-FDG PET/CT. J Nucl Med. 2007; 48: 1053-1059.
14. Spier BJ, Perlman SB, Jaskowiak CJ, et al. PET/CT in the evaluation of inflammatory bowel disease: studies in patients before and after treatment. Mol Imaging Biol. 2010; 12: 85-88.
15. Jacene HA, Ginsburg P, Kwon J, et al. Prediction of the need for surgical intervention in obstructive Crohn's disease by 18F-FDG PET/CT. J Nucl Med. 2009; 50: 1751-1759.
16. Ahmadi A, Li Q, Muller K, et al. Diagnostic value of noninvasive combined fluorine-18 labeled fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography enterography in active Crohn's disease. Inflamm Bowel Dis. 2010; 16: 974-981.
17. Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's Disease Activity Index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976; 70: 439-444.
18. Limberg B,. [Diagnosis of chronic inflammatory bowel disease by ultrasonography.] Z Gastroenterol. 1999; 37: 495-508.
19. Stange EF, Travis SP, Vermeire S, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut. 2006; 55 (Suppl 1): i1-15.
20. Fletcher JW, Djulbegovic B, Soares HP, et al. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med. 2008; 49: 480-508.
21. Horsthuis K, Bipat S, Bennink RJ, et al. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology. 2008; 247: 64-79.
22. Brenner DJ, Hall EJ,. Computed tomography-an increasing source of radiation exposure. N Engl J Med. 2007; 357: 2277-2284.
23. Desmond AN, O'Regan K, Curran C, et al. Crohn's disease: factors associated with exposure to high levels of diagnostic radiation. Gut. 2008; 57: 1524-1529.
24. Terheggen G, Lanyi B, Schanz S, et al. Safety, feasibility, and tolerability of ileocolonoscopy in inflammatory bowel disease. Endoscopy. 2008; 40: 656-663.
25. Panes J, Bouzas R, Chaparro M, et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease. Aliment Pharmacol Ther. 2011; 34: 125-145.